Drug
Incb054707
Incb054707: highest development phase Phase 1, developed by Incyte. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Incyte
Trials
| Drug | Phase | Indication |
|---|---|---|
| INCB054707 NCT05624723 | Phase 1 | Renal Insufficiency |
Latest
No recent events.
Follow Incb054707 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.